
Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 30, 2025, titled "Receipt of EIR from USFDA for inspection conducted at manufacturing facility of Company s subsidiary Time-Cap Laboratories, Inc.".
Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 30, 2025, titled "Receipt of EIR from USFDA for inspection conducted at manufacturing facility of Company s subsidiary Time-Cap Laboratories, Inc.".
6ix hasn’t read this filing yet.
Marksans Pharma Limited on 6ix
Follow Marksans Pharma into a list and get an email when it puts out news.
Follow Marksans Pharma